Development and validation of a m6A-related gene signature for predicting the prognosis of hepatocellular carcinoma

被引：5
|
作者：
Kong, Weihao [1 ]
Li, Xutong [2 ]
Xu, Honghai [3 ]
Gao, Yufeng [2 ]
机构：
[1] Anhui Med Univ, Dept Emergency Surg, Dept Emergency Med, Affiliated Hosp 1, Hefei 230022, Peoples R China
[2] Anhui Med Univ, Dept Infect Dis, Affiliated Hosp 1, Hefei 230022, Peoples R China
[3] Anhui Med Univ, Affiliated Hosp 1, Dept Pathol, Hefei 230022, Peoples R China
来源：
BIOMARKERS IN MEDICINE | 2020年 / 14卷 / 13期
关键词：
liver cancer; m(6)A RNA methylation; prognosis; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER;
D O I：
10.2217/bmm-2020-0178
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Background:This study aimed to investigate the prognostic role of m(6)A methylation regulators in hepatocellular carcinoma (HCC).Materials & methods:Gene expression matrices were downloaded from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium, and Gene Expression Omnibus databases. Univariate and multivariate regression analysis were utilized to determine the m(6)A risk genes.Results:Two m(6)A-related risk genes (YTHDF1, YTHDF2) were identified in the TCGA HCC cohort. The m(6)A-correlated risk score is an independent risk factor for the overall survival of the TCGA HCC cohort. Finally, we verified the reliability of our results using three external datasets.Conclusion:The m(6)A-correlated gene signature has prognostic value in HCC patients and thus provides guidance for the treatment of HCC.
引用
收藏
页码：1217 / 1228
页数：12
相关论文
共 50 条
  • [1] An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
    Zhang, Zhenyu
    Wang, Fangkai
    Zhang, Jianlin
    Zhan, Wenjing
    Zhang, Gaosong
    Li, Chong
    Zhang, Tongyuan
    Yuan, Qianqian
    Chen, Jia
    Guo, Manyu
    Xu, Honghai
    Yu, Feng
    Wang, Hengyi
    Wang, Xingyu
    Kong, Weihao
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [2] The m6A-related gene signature for predicting the prognosis of breast cancer
    Zhong, Shanliang
    Lin, Zhenzhong
    Chen, Huanwen
    Mao, Ling
    Feng, Jifeng
    Zhou, Siying
    PEERJ, 2021, 9
  • [3] A novel m6A-related prognostic signature for predicting the overall survival of hepatocellular carcinoma patients
    Xie, Shiyang
    Wang, Yaxuan
    Huang, Jin
    Li, Guang
    IET SYSTEMS BIOLOGY, 2022, 16 (01) : 1 - 17
  • [4] Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma
    Ding, Jianfeng
    He, Xiaobo
    Luo, Wei
    Zhou, Weiguo
    Chen, Rui
    Cao, Guodong
    Chen, Bo
    Xiong, Maoming
    FRONTIERS IN GENETICS, 2022, 13
  • [5] Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
    Zhu, Yuezhi
    Tan, Jen Kit
    Goon, Jo Aan
    BIOLOGY-BASEL, 2023, 12 (08):
  • [6] Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer
    Song, Yang
    Qu, Hui
    BMC CANCER, 2022, 22 (01)
  • [7] Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer
    Yang Song
    Hui Qu
    BMC Cancer, 22
  • [8] Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
    Kong, Weihao
    Wang, Xingyu
    Zuo, Xiaomin
    Mao, Zhongxiang
    Cheng, Ya
    Chen, Wei
    FRONTIERS IN GENETICS, 2020, 11
  • [9] Development and Validation of a Novel Ferroptosis-Related Gene Signature for Prognosis and Immunotherapy in Hepatocellular Carcinoma
    Zhang, Bo
    Zhao, Jilong
    Liu, Bing
    Shang, Yanan
    Chen, Fei
    Zhang, Sidi
    He, Jiayao
    Fan, Yumei
    Tan, Ke
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [10] Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
    Ma, Yiming
    Yang, Jun
    Ji, Tiantai
    Wen, Fengyun
    FRONTIERS IN GENETICS, 2022, 13
12345